Indication
To induce the production of antibodies to Infectious Bursal Disease (IBD) virus by breeder hens and the transfer of passive immunity to their progeny.
As an aid in the prevention of avian Reovirus infections.
Presentation
1000 doses of inactivated Infectious Bursal Disease virus and inactivated Reo virus per 500 ml bottle.
Vaccination Program
Breeders are given one attenuated live primer vaccination with Bursine®-2 at 6 to 8 weeks-of-age followed by vaccination with inactivated Poulvac Maternavac® IBD-REO between 16 and 22 weeks-of-age (4 weeks prior to lay).
Vaccine administration
From 16 to 22 weeks-of-age administer 0.5 ml Poulvac Maternavac® IBD-REO by intramuscular or subcutaneous injection.
Poulvac Maternavac IBD REO
Precautions
Store refrigerated at 2 to 70 C. Do not allow to freeze.
Do not expose to disinfectants or heat.
Further Information
Disease Information
Infectious Bursal Disease (IBD) [Gumboro Disease]
Administration Information Sheet
Intramuscular injectionSubcutaneous injection
Safety Data Sheet
Poulvac Maternavac IBD REO Safety Data Sheet
Product Information Sheet
Poulvac Maternavac IBD REO